The selected CSCs highly co-expressed CD44 and CD24 in TW01, TW06, and HONE-1 NPC cell lines and showed increment of cells with CD44+/CD24+ expression from around 30–60% in parental cells to 90% in CSCs (Figure 1A). This evidence concerns the gene CD24 and nasopharyngeal carcinoma.